1 Study Coverage 1.1 Non-Invasive Drug Delivery Product Introduction 1.2 Market by Type 1.2.1 Global Non-Invasive Drug Delivery Market Size Growth Rate by Type 1.2.2 Artificial Pancreas 1.2.3 Needle Free Injector 1.2.4 Digital Respiratory Devices 1.2.5 Other 1.3 Market by Application 1.3.1 Global Non-Invasive Drug Delivery Market Size Growth Rate by Application 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Other 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Non-Invasive Drug Delivery Market Size, Estimates and Forecasts 2.1.1 Global Non-Invasive Drug Delivery Revenue 2016-2027 2.1.2 Global Non-Invasive Drug Delivery Sales 2016-2027 2.2 Global Non-Invasive Drug Delivery, Market Size by Region: 2016 VS 2021 VS 2027 2.3 Non-Invasive Drug Delivery Historical Market Size by Region (2016-2021) 2.3.1 Global Non-Invasive Drug Delivery Retrospective Market Scenario in Sales by Region: 2016-2021 2.3.2 Global Non-Invasive Drug Delivery Retrospective Market Scenario in Revenue by Region: 2016-2021 2.4 Non-Invasive Drug Delivery Market Estimates and Projections by Region (2022-2027) 2.4.1 Global Non-Invasive Drug Delivery Sales Forecast by Region (2022-2027) 2.4.2 Global Non-Invasive Drug Delivery Revenue Forecast by Region (2022-2027) 3 Global Non-Invasive Drug Delivery Competitor Landscape by Players 3.1 Global Top Non-Invasive Drug Delivery Manufacturers by Sales 3.1.1 Global Non-Invasive Drug Delivery Sales by Manufacturer (2016-2021) 3.1.2 Global Non-Invasive Drug Delivery Sales Market Share by Manufacturer (2016-2021) 3.2 Global Top Non-Invasive Drug Delivery Manufacturers by Revenue 3.2.1 Key Non-Invasive Drug Delivery Manufacturers Covered: Ranking by Revenue 3.2.2 Global Non-Invasive Drug Delivery Revenue by Manufacturers (2016-2021) 3.2.3 Global Non-Invasive Drug Delivery Revenue Share by Manufacturers (2016-2021) 3.2.4 Global Non-Invasive Drug Delivery Market Concentration Ratio (CR5 and HHI) (2016-2021) 3.2.5 Global Top 10 and Top 5 Companies by Non-Invasive Drug Delivery Revenue in 2020 3.2.6 Global Non-Invasive Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global Non-Invasive Drug Delivery Price by Manufacturers 3.4 Global Non-Invasive Drug Delivery Manufacturing Base Distribution, Product Types 3.4.1 Non-Invasive Drug Delivery Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Non-Invasive Drug Delivery Product Type 3.4.3 Date of International Manufacturers Enter into Non-Invasive Drug Delivery Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2016-2027) 4.1 Global Non-Invasive Drug Delivery Market Size by Type (2016-2021) 4.1.1 Global Non-Invasive Drug Delivery Sales by Type (2016-2021) 4.1.2 Global Non-Invasive Drug Delivery Revenue by Type (2016-2021) 4.1.3 Non-Invasive Drug Delivery Average Selling Price (ASP) by Type (2016-2021) 4.2 Global Non-Invasive Drug Delivery Market Size Forecast by Type (2022-2027) 4.2.1 Global Non-Invasive Drug Delivery Sales Forecast by Type (2022-2027) 4.2.2 Global Non-Invasive Drug Delivery Revenue Forecast by Type (2022-2027) 4.2.3 Non-Invasive Drug Delivery Average Selling Price (ASP) Forecast by Type (2022-2027) 5 Breakdown Data by Application (2016-2027) 5.1 Global Non-Invasive Drug Delivery Market Size by Application (2016-2021) 5.1.1 Global Non-Invasive Drug Delivery Sales by Application (2016-2021) 5.1.2 Global Non-Invasive Drug Delivery Revenue by Application (2016-2021) 5.1.3 Non-Invasive Drug Delivery Price by Application (2016-2021) 5.2 Non-Invasive Drug Delivery Market Size Forecast by Application (2022-2027) 5.2.1 Global Non-Invasive Drug Delivery Sales Forecast by Application (2022-2027) 5.2.2 Global Non-Invasive Drug Delivery Revenue Forecast by Application (2022-2027) 5.2.3 Global Non-Invasive Drug Delivery Price Forecast by Application (2022-2027) 6 Japan by Players, Type and Application 6.1 Japan Non-Invasive Drug Delivery Market Size YoY Growth 2016-2027 6.1.1 Japan Non-Invasive Drug Delivery Sales YoY Growth 2016-2027 6.1.2 Japan Non-Invasive Drug Delivery Revenue YoY Growth 2016-2027 6.1.3 Japan Non-Invasive Drug Delivery Market Share in Global Market 2016-2027 6.2 Japan Non-Invasive Drug Delivery Market Size by Players (International and Local Players) 6.2.1 Japan Top Non-Invasive Drug Delivery Players by Sales (2016-2021) 6.2.2 Japan Top Non-Invasive Drug Delivery Players by Revenue (2016-2021) 6.3 Japan Non-Invasive Drug Delivery Historic Market Review by Type (2016-2021) 6.3.1 Japan Non-Invasive Drug Delivery Sales Market Share by Type (2016-2021) 6.3.2 Japan Non-Invasive Drug Delivery Revenue Market Share by Type (2016-2021) 6.3.3 Japan Non-Invasive Drug Delivery Price by Type (2016-2021) 6.4 Japan Non-Invasive Drug Delivery Market Estimates and Forecasts by Type (2022-2027) 6.4.1 Japan Non-Invasive Drug Delivery Sales Forecast by Type (2022-2027) 6.4.2 Japan Non-Invasive Drug Delivery Revenue Forecast by Type (2022-2027) 6.4.3 Japan Non-Invasive Drug Delivery Price Forecast by Type (2022-2027) 6.5 Japan Non-Invasive Drug Delivery Historic Market Review by Application (2016-2021) 6.5.1 Japan Non-Invasive Drug Delivery Sales Market Share by Application (2016-2021) 6.5.2 Japan Non-Invasive Drug Delivery Revenue Market Share by Application (2016-2021) 6.5.3 Japan Non-Invasive Drug Delivery Price by Application (2016-2021) 6.6 Japan Non-Invasive Drug Delivery Market Estimates and Forecasts by Application (2022-2027) 6.6.1 Japan Non-Invasive Drug Delivery Sales Forecast by Application (2022-2027) 6.6.2 Japan Non-Invasive Drug Delivery Revenue Forecast by Application (2022-2027) 6.6.3 Japan Non-Invasive Drug Delivery Price Forecast by Application (2022-2027) 7 North America 7.1 North America Non-Invasive Drug Delivery Market Size YoY Growth 2016-2027 7.2 North America Non-Invasive Drug Delivery Market Facts & Figures by Country 7.2.1 North America Non-Invasive Drug Delivery Sales by Country (2016-2021) 7.2.2 North America Non-Invasive Drug Delivery Revenue by Country (2016-2021) 7.2.3 U.S. 7.2.4 Canada 8 Asia Pacific 8.1 Asia Pacific Non-Invasive Drug Delivery Market Size YoY Growth 2016-2027 8.2 Asia Pacific Non-Invasive Drug Delivery Market Facts & Figures by Region 8.2.1 Asia Pacific Non-Invasive Drug Delivery Sales by Region (2016-2021) 8.2.2 Asia Pacific Non-Invasive Drug Delivery Revenue by Region (2016-2021) 8.2.3 China 8.2.4 Japan 8.2.5 South Korea 8.2.6 India 8.2.7 Australia 8.2.8 Australia 8.2.9 Indonesia 8.2.10 Thailand 8.2.11 Malaysia 8.2.12 Philippines 8.2.13 Vietnam 9 Europe 9.1 Europe Non-Invasive Drug Delivery Market Size YoY Growth 2016-2027 9.2 Europe Non-Invasive Drug Delivery Market Facts & Figures by Country 9.2.1 Europe Non-Invasive Drug Delivery Sales by Country (2016-2021) 9.2.2 Europe Non-Invasive Drug Delivery Revenue by Country (2016-2021) 9.2.3 Germany 9.2.4 France 9.2.5 U.K. 9.2.6 Italy 10 Latin America 10.1 Latin America Non-Invasive Drug Delivery Market Size YoY Growth 2016-2027 10.2 Latin America Non-Invasive Drug Delivery Market Facts & Figures by Country 10.2.1 Latin America Non-Invasive Drug Delivery Sales by Country (2016-2021) 10.2.2 Latin America Non-Invasive Drug Delivery Revenue by Country (2016-2021) 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Non-Invasive Drug Delivery Market Size YoY Growth 2016-2027 11.2 Middle East and Africa Non-Invasive Drug Delivery Market Facts & Figures by Country 11.2.1 Middle East and Africa Non-Invasive Drug Delivery Sales by Country (2016-2021) 11.2.2 Middle East and Africa Non-Invasive Drug Delivery Revenue by Country (2016-2021) 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 UAE 12 Company Profiles 12.1 Adherium Limited 12.1.1 Adherium Limited Corporation Information 12.1.2 Adherium Limited Description and Business Overview 12.1.3 Adherium Limited Non-Invasive Drug Delivery Sales, Revenue and Gross Margin (2016-2021) 12.1.4 Adherium Limited Non-Invasive Drug Delivery Products Offered 12.1.5 Adherium Limited Recent Development 12.2 Capsule Technologies, Inc. 12.2.1 Capsule Technologies, Inc. Corporation Information 12.2.2 Capsule Technologies, Inc. Description and Business Overview 12.2.3 Capsule Technologies, Inc. Non-Invasive Drug Delivery Sales, Revenue and Gross Margin (2016-2021) 12.2.4 Capsule Technologies, Inc. Non-Invasive Drug Delivery Products Offered 12.2.5 Capsule Technologies, Inc. Recent Development 12.3 Crossject S.A. 12.3.1 Crossject S.A. Corporation Information 12.3.2 Crossject S.A. Description and Business Overview 12.3.3 Crossject S.A. Non-Invasive Drug Delivery Sales, Revenue and Gross Margin (2016-2021) 12.3.4 Crossject S.A. Non-Invasive Drug Delivery Products Offered 12.3.5 Crossject S.A. Recent Development 12.4 Diabeloop SA 12.4.1 Diabeloop SA Corporation Information 12.4.2 Diabeloop SA Description and Business Overview 12.4.3 Diabeloop SA Non-Invasive Drug Delivery Sales, Revenue and Gross Margin (2016-2021) 12.4.4 Diabeloop SA Non-Invasive Drug Delivery Products Offered 12.4.5 Diabeloop SA Recent Development 12.5 HNS International, Inc. 12.5.1 HNS International, Inc. Corporation Information 12.5.2 HNS International, Inc. Description and Business Overview 12.5.3 HNS International, Inc. Non-Invasive Drug Delivery Sales, Revenue and Gross Margin (2016-2021) 12.5.4 HNS International, Inc. Non-Invasive Drug Delivery Products Offered 12.5.5 HNS International, Inc. Recent Development 12.6 Inovio Pharmaceuticals, Inc. 12.6.1 Inovio Pharmaceuticals, Inc. Corporation Information 12.6.2 Inovio Pharmaceuticals, Inc. Description and Business Overview 12.6.3 Inovio Pharmaceuticals, Inc. Non-Invasive Drug Delivery Sales, Revenue and Gross Margin (2016-2021) 12.6.4 Inovio Pharmaceuticals, Inc. Non-Invasive Drug Delivery Products Offered 12.6.5 Inovio Pharmaceuticals, Inc. Recent Development 12.7 Medtronic Plc. 12.7.1 Medtronic Plc. Corporation Information 12.7.2 Medtronic Plc. Description and Business Overview 12.7.3 Medtronic Plc. Non-Invasive Drug Delivery Sales, Revenue and Gross Margin (2016-2021) 12.7.4 Medtronic Plc. Non-Invasive Drug Delivery Products Offered 12.7.5 Medtronic Plc. Recent Development 12.8 Novartis AG 12.8.1 Novartis AG Corporation Information 12.8.2 Novartis AG Description and Business Overview 12.8.3 Novartis AG Non-Invasive Drug Delivery Sales, Revenue and Gross Margin (2016-2021) 12.8.4 Novartis AG Non-Invasive Drug Delivery Products Offered 12.8.5 Novartis AG Recent Development 12.9 PenJet Corporation 12.9.1 PenJet Corporation Corporation Information 12.9.2 PenJet Corporation Description and Business Overview 12.9.3 PenJet Corporation Non-Invasive Drug Delivery Sales, Revenue and Gross Margin (2016-2021) 12.9.4 PenJet Corporation Non-Invasive Drug Delivery Products Offered 12.9.5 PenJet Corporation Recent Development 12.10 PharmaJet 12.10.1 PharmaJet Corporation Information 12.10.2 PharmaJet Description and Business Overview 12.10.3 PharmaJet Non-Invasive Drug Delivery Sales, Revenue and Gross Margin (2016-2021) 12.10.4 PharmaJet Non-Invasive Drug Delivery Products Offered 12.10.5 PharmaJet Recent Development 12.11 Adherium Limited 12.11.1 Adherium Limited Corporation Information 12.11.2 Adherium Limited Description and Business Overview 12.11.3 Adherium Limited Non-Invasive Drug Delivery Sales, Revenue and Gross Margin (2016-2021) 12.11.4 Adherium Limited Non-Invasive Drug Delivery Products Offered 12.11.5 Adherium Limited Recent Development 12.12 ResMed 12.12.1 ResMed Corporation Information 12.12.2 ResMed Description and Business Overview 12.12.3 ResMed Non-Invasive Drug Delivery Sales, Revenue and Gross Margin (2016-2021) 12.12.4 ResMed Products Offered 12.12.5 ResMed Recent Development 12.13 Sensiron AG 12.13.1 Sensiron AG Corporation Information 12.13.2 Sensiron AG Description and Business Overview 12.13.3 Sensiron AG Non-Invasive Drug Delivery Sales, Revenue and Gross Margin (2016-2021) 12.13.4 Sensiron AG Products Offered 12.13.5 Sensiron AG Recent Development 12.14 Tandem Diabetes Care, Inc. 12.14.1 Tandem Diabetes Care, Inc. Corporation Information 12.14.2 Tandem Diabetes Care, Inc. Description and Business Overview 12.14.3 Tandem Diabetes Care, Inc. Non-Invasive Drug Delivery Sales, Revenue and Gross Margin (2016-2021) 12.14.4 Tandem Diabetes Care, Inc. Products Offered 12.14.5 Tandem Diabetes Care, Inc. Recent Development 12.15 Teva Pharmaceuticals Industries Ltd. 12.15.1 Teva Pharmaceuticals Industries Ltd. Corporation Information 12.15.2 Teva Pharmaceuticals Industries Ltd. Description and Business Overview 12.15.3 Teva Pharmaceuticals Industries Ltd. Non-Invasive Drug Delivery Sales, Revenue and Gross Margin (2016-2021) 12.15.4 Teva Pharmaceuticals Industries Ltd. Products Offered 12.15.5 Teva Pharmaceuticals Industries Ltd. Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Non-Invasive Drug Delivery Industry Trends 13.2 Non-Invasive Drug Delivery Market Drivers 13.3 Non-Invasive Drug Delivery Market Challenges 13.4 Non-Invasive Drug Delivery Market Restraints 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Non-Invasive Drug Delivery Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables Table 1. Global Non-Invasive Drug Delivery Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of Artificial Pancreas Table 3. Major Manufacturers of Needle Free Injector Table 4. Major Manufacturers of Digital Respiratory Devices Table 5. Major Manufacturers of Other Table 6. Global Non-Invasive Drug Delivery Market Size Growth Rate by Application (2021-2027) & (K Units) Table 7. Global Non-Invasive Drug Delivery Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027 Table 8. Global Non-Invasive Drug Delivery Sales by Regions (2016-2021) & (K Units) Table 9. Global Non-Invasive Drug Delivery Sales Market Share by Regions (2016-2021) Table 10. Global Non-Invasive Drug Delivery Revenue by Regions (2016-2021) & (US$ Million) Table 11. Global Non-Invasive Drug Delivery Sales Forecast by Region (2022-2027) & (K Units) Table 12. Global Non-Invasive Drug Delivery Sales Market Share Forecast by Region (2022-2027) Table 13. Global Non-Invasive Drug Delivery Revenue Forecast by Region (2022-2027) & (US$ Million) Table 14. Global Non-Invasive Drug Delivery Revenue Market Share Forecast by Region (2022-2027) Table 15. Global Non-Invasive Drug Delivery Sales by Manufacturers (2016-2021) (K Units) Table 16. Global Non-Invasive Drug Delivery Sales Share by Manufacturers (2016-2021) Table 17. Ranking of Global Top Non-Invasive Drug Delivery Manufacturers by Revenue (US$ Million) in 2020 Table 18. Non-Invasive Drug Delivery Revenue by Manufacturers (2016-2021) (US$ Million) Table 19. Non-Invasive Drug Delivery Revenue Share by Manufacturers (2016-2021) Table 20. Global Non-Invasive Drug Delivery Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021) Table 21. Global Non-Invasive Drug Delivery by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-Invasive Drug Delivery as of 2020) Table 22. Key Manufacturers Non-Invasive Drug Delivery Price (2016-2021) (US$/Unit) Table 23. Non-Invasive Drug Delivery Manufacturers Manufacturing Base Distribution and Headquarters Table 24. Manufacturers Non-Invasive Drug Delivery Product Type Table 25. Date of International Manufacturers Enter into Non-Invasive Drug Delivery Market Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans Table 27. Global Non-Invasive Drug Delivery Sales by Type (2016-2021) (K Units) Table 28. Global Non-Invasive Drug Delivery Sales Share by Type (2016-2021) Table 29. Global Non-Invasive Drug Delivery Revenue by Type (2016-2021) (US$ Million) Table 30. Global Non-Invasive Drug Delivery Revenue Share by Type (2016-2021) Table 31. Non-Invasive Drug Delivery Average Selling Price (ASP) by Type (2016-2021) & (US$/Unit) Table 32. Global Non-Invasive Drug Delivery Sales Forecast by Type (2022-2027) & (K Units) Table 33. Global Non-Invasive Drug Delivery Sales Market Share Forecast by Type (2022-2027) Table 34. Global Non-Invasive Drug Delivery Revenue Forecast V (2022-2027) & (US$ Million) Table 35. Global Non-Invasive Drug Delivery Revenue Market Share Forecast by Type (2022-2027) Table 36. Global Non-Invasive Drug Delivery Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Unit) Table 37. Global Non-Invasive Drug Delivery Sales by Application (2016-2021) (K Units) Table 38. Global Non-Invasive Drug Delivery Sales Share by Application (2016-2021) Table 39. Global Non-Invasive Drug Delivery Revenue by Application (2016-2021) (US$ Million) Table 40. Global Non-Invasive Drug Delivery Revenue Share by Application (2016-2021) Table 41. Non-Invasive Drug Delivery Average Selling Price (ASP) by Application (2016-2021) & (US$/Unit) Table 42. Global Non-Invasive Drug Delivery Sales Forecast by Application (2022-2027) & (K Units) Table 43. Global Non-Invasive Drug Delivery Sales Market Share Forecast by Application (2022-2027) Table 44. Global Non-Invasive Drug Delivery Revenue Forecast by Application (2022-2027) & (US$ Million) Table 45. Global Non-Invasive Drug Delivery Revenue Market Share Forecast by Application (2022-2027) Table 46. Global Non-Invasive Drug Delivery Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Unit) Table 47. Japan Non-Invasive Drug Delivery Sales (K Units) of Key Companies (2016-2021) Table 48. Japan Non-Invasive Drug Delivery Sales Share by Company (2016-2021) Table 49. Japan Non-Invasive Drug Delivery Revenue (US$ Million) by Company (2016-2021) Table 50. Japan Non-Invasive Drug Delivery Revenue Share by Company (2016-2021) Table 51. Japan Non-Invasive Drug Delivery Sales (K Units) by Type (2016-2021) Table 52. Japan Non-Invasive Drug Delivery Sales Share by Type (2016-2021) Table 53. Japan Non-Invasive Drug Delivery Revenue (US$ Million) Market Share by Type (2016-2021) Table 54. Japan Non-Invasive Drug Delivery Price (US$/Unit) by Type (2016-2021) Table 55. Japan Non-Invasive Drug Delivery Sales (K Units) by Type (2022-2027) Table 56. Japan Non-Invasive Drug Delivery Sales Share by Type (2022-2027) Table 57. Japan Non-Invasive Drug Delivery Revenue (US$ Million) Market Share by Type (2022-2027) Table 58. Japan Non-Invasive Drug Delivery Revenue Share by Type (2022-2027) Table 59. Japan Non-Invasive Drug Delivery Price (US$/Unit) by Type (2022-2027) Table 60. Japan Non-Invasive Drug Delivery Sales (K Units) by Application (2016-2021) Table 61. Japan Non-Invasive Drug Delivery Sales Share by Application (2016-2021) Table 62. Japan Non-Invasive Drug Delivery Revenue (US$ Million) Market Share by Application (2016-2021) Table 63. Japan Non-Invasive Drug Delivery Price (US$/Unit) by Application (2016-2021) Table 64. Japan Non-Invasive Drug Delivery Sales (K Units) by Application (2022-2027) Table 65. Japan Non-Invasive Drug Delivery Sales Share by Application (2022-2027) Table 66. Japan Non-Invasive Drug Delivery Revenue (US$ Million) Market Share by Application (2022-2027) Table 67. Japan Non-Invasive Drug Delivery Revenue Share by Application (2022-2027) Table 68. Japan Non-Invasive Drug Delivery Price (US$/Unit) by Application (2022-2027) Table 69. North America Non-Invasive Drug Delivery Sales by Country (2016-2021) & (K Units) Table 70. North America Non-Invasive Drug Delivery Sales Market Share by Country (2016-2021) Table 71. North America Non-Invasive Drug Delivery Revenue by Country (2016-2021) & (US$ Million) Table 72. North America Non-Invasive Drug Delivery Revenue Market Share by Country (2016-2021) Table 73. Asia Pacific Non-Invasive Drug Delivery Sales by Region (2016-2021) & (K Units) Table 74. Asia Pacific Non-Invasive Drug Delivery Sales Market Share by Region (2016-2021) Table 75. Asia Pacific Non-Invasive Drug Delivery Revenue by Region (2016-2021) & (US$ Million) Table 76. Asia Pacific Non-Invasive Drug Delivery Revenue Market Share by Region (2016-2021) Table 77. Europe Non-Invasive Drug Delivery Sales by Country (2016-2021) & (K Units) Table 78. Europe Non-Invasive Drug Delivery Sales Market Share by Country (2016-2021) Table 79. Europe Non-Invasive Drug Delivery Revenue by Country (2016-2021) & (US$ Million) Table 80. Europe Non-Invasive Drug Delivery Revenue Market Share by Country (2016-2021) Table 81. Latin America Non-Invasive Drug Delivery Sales by Country (2016-2021) & (K Units) Table 82. Latin America Non-Invasive Drug Delivery Sales Market Share by Country (2016-2021) Table 83. Latin Americaa Non-Invasive Drug Delivery Revenue by Country (2016-2021) & (US$ Million) Table 84. Latin America Non-Invasive Drug Delivery Revenue Market Share by Country (2016-2021) Table 85. Middle East and Africa Non-Invasive Drug Delivery Sales by Country (2016-2021) & (K Units) Table 86. Middle East and Africa Non-Invasive Drug Delivery Sales Market Share by Country (2016-2021) Table 87. Middle East and Africa Non-Invasive Drug Delivery Revenue by Country (2016-2021) & (US$ Million) Table 88. Middle East and Africa Non-Invasive Drug Delivery Revenue Market Share by Country (2016-2021) Table 89. Adherium Limited Corporation Information Table 90. Adherium Limited Description and Business Overview Table 91. Adherium Limited Non-Invasive Drug Delivery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 92. Adherium Limited Non-Invasive Drug Delivery Product Table 93. Adherium Limited Recent Development Table 94. Capsule Technologies, Inc. Corporation Information Table 95. Capsule Technologies, Inc. Description and Business Overview Table 96. Capsule Technologies, Inc. Non-Invasive Drug Delivery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 97. Capsule Technologies, Inc. Product Table 98. Capsule Technologies, Inc. Recent Development Table 99. Crossject S.A. Corporation Information Table 100. Crossject S.A. Description and Business Overview Table 101. Crossject S.A. Non-Invasive Drug Delivery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 102. Crossject S.A. Product Table 103. Crossject S.A. Recent Development Table 104. Diabeloop SA Corporation Information Table 105. Diabeloop SA Description and Business Overview Table 106. Diabeloop SA Non-Invasive Drug Delivery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 107. Diabeloop SA Product Table 108. Diabeloop SA Recent Development Table 109. HNS International, Inc. Corporation Information Table 110. HNS International, Inc. Description and Business Overview Table 111. HNS International, Inc. Non-Invasive Drug Delivery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 112. HNS International, Inc. Product Table 113. HNS International, Inc. Recent Development Table 114. Inovio Pharmaceuticals, Inc. Corporation Information Table 115. Inovio Pharmaceuticals, Inc. Description and Business Overview Table 116. Inovio Pharmaceuticals, Inc. Non-Invasive Drug Delivery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 117. Inovio Pharmaceuticals, Inc. Product Table 118. Inovio Pharmaceuticals, Inc. Recent Development Table 119. Medtronic Plc. Corporation Information Table 120. Medtronic Plc. Description and Business Overview Table 121. Medtronic Plc. Non-Invasive Drug Delivery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 122. Medtronic Plc. Product Table 123. Medtronic Plc. Recent Development Table 124. Novartis AG Corporation Information Table 125. Novartis AG Description and Business Overview Table 126. Novartis AG Non-Invasive Drug Delivery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 127. Novartis AG Product Table 128. Novartis AG Recent Development Table 129. PenJet Corporation Corporation Information Table 130. PenJet Corporation Description and Business Overview Table 131. PenJet Corporation Non-Invasive Drug Delivery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 132. PenJet Corporation Product Table 133. PenJet Corporation Recent Development Table 134. PharmaJet Corporation Information Table 135. PharmaJet Description and Business Overview Table 136. PharmaJet Non-Invasive Drug Delivery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 137. PharmaJet Product Table 138. PharmaJet Recent Development Table 139. Portal Instruments Corporation Information Table 140. Portal Instruments Description and Business Overview Table 141. Portal Instruments Non-Invasive Drug Delivery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 142. Portal Instruments Product Table 143. Portal Instruments Recent Development Table 144. ResMed Corporation Information Table 145. ResMed Description and Business Overview Table 146. ResMed Non-Invasive Drug Delivery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 147. ResMed Product Table 148. ResMed Recent Development Table 149. Sensiron AG Corporation Information Table 150. Sensiron AG Description and Business Overview Table 151. Sensiron AG Non-Invasive Drug Delivery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 152. Sensiron AG Product Table 153. Sensiron AG Recent Development Table 154. Tandem Diabetes Care, Inc. Corporation Information Table 155. Tandem Diabetes Care, Inc. Description and Business Overview Table 156. Tandem Diabetes Care, Inc. Non-Invasive Drug Delivery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 157. Tandem Diabetes Care, Inc. Product Table 158. Tandem Diabetes Care, Inc. Recent Development Table 159. Teva Pharmaceuticals Industries Ltd. Corporation Information Table 160. Teva Pharmaceuticals Industries Ltd. Description and Business Overview Table 161. Teva Pharmaceuticals Industries Ltd. Non-Invasive Drug Delivery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 162. Teva Pharmaceuticals Industries Ltd. Product Table 163. Teva Pharmaceuticals Industries Ltd. Recent Development Table 164. Non-Invasive Drug Delivery Market Trends Table 165. Non-Invasive Drug Delivery Market Drivers Table 166. Non-Invasive Drug Delivery Market Challenges Table 167. Non-Invasive Drug Delivery Market Restraints Table 168. Non-Invasive Drug Delivery Customers List Table 169. Non-Invasive Drug Delivery Distributors List Table 170. Research Programs/Design for This Report Table 171. Key Data Information from Secondary Sources Table 172. Key Data Information from Primary Sources List of Figures Figure 1. Non-Invasive Drug Delivery Product Picture Figure 2. Global Non-Invasive Drug Delivery Sales Market Share by Type in 2020 & 2027 Figure 3. Artificial Pancreas Product Picture Figure 4. Needle Free Injector Product Picture Figure 5. Digital Respiratory Devices Product Picture Figure 6. Other Product Picture Figure 7. Global Non-Invasive Drug Delivery Sales Market Share by Application in 2020 & 2027 Figure 8. Hospital Figure 9. Clinic Figure 10. Other Figure 11. Non-Invasive Drug Delivery Report Years Considered Figure 12. Global Non-Invasive Drug Delivery Market Size, (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global Non-Invasive Drug Delivery Market Size 2016-2027 (US$ Million) Figure 14. Global Non-Invasive Drug Delivery Sales 2016-2027 (K Units) Figure 15. Global Non-Invasive Drug Delivery Market Size Market Share by Region: 2021 Versus 2027 Figure 16. Global Non-Invasive Drug Delivery Sales Market Share by Region (2016-2021) Figure 17. Global Non-Invasive Drug Delivery Sales Market Share by Region in 2020 Figure 18. Global Non-Invasive Drug Delivery Revenue Market Share by Region (2016-2021) Figure 19. Global Non-Invasive Drug Delivery Revenue Market Share by Region in 2020 Figure 20. Global Non-Invasive Drug Delivery Sales Share by Manufacturer in 2020 Figure 21. The Top 10 and 5 Players Market Share by Non-Invasive Drug Delivery Revenue in 2020 Figure 22. Non-Invasive Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 23. Global Non-Invasive Drug Delivery Sales Market Share by Type (2016-2021) Figure 24. Global Non-Invasive Drug Delivery Sales Market Share by Type in 2020 Figure 25. Global Non-Invasive Drug Delivery Revenue Market Share by Type (2016-2021) Figure 26. Global Non-Invasive Drug Delivery Revenue Market Share by Type in 2020 Figure 27. Global Non-Invasive Drug Delivery Sales Market Share by Application (2016-2021) Figure 28. Global Non-Invasive Drug Delivery Sales Market Share by Application in 2020 Figure 29. Global Non-Invasive Drug Delivery Revenue Market Share by Application (2016-2021) Figure 30. Global Non-Invasive Drug Delivery Revenue Market Share by Application in 2020 Figure 31. Japan Non-Invasive Drug Delivery Sales Growth Rate 2016-2027 (K Units) Figure 32. Japan Non-Invasive Drug Delivery Revenue Growth Rate 2016-2027 (US$ Million) Figure 33. Japan Non-Invasive Drug Delivery Market Share in Global Market 2016-2027 Figure 34. Japan 5 and 10 Largest Non-Invasive Drug Delivery Players Market Share by Revenue in Non-Invasive Drug Delivery in 2020 Figure 35. Japan Non-Invasive Drug Delivery Revenue Share by Type (2016-2021) Figure 36. Japan Non-Invasive Drug Delivery Revenue Growth Rate by Type in 2016 & 2020 Figure 37. Japan Non-Invasive Drug Delivery Revenue Share by Application (2016-2021) Figure 38. Japan Non-Invasive Drug Delivery Revenue Growth Rate by Application in 2016 & 2020 Figure 39. North America Non-Invasive Drug Delivery Sales Growth Rate 2016-2021 (K Units) Figure 40. North America Non-Invasive Drug Delivery Revenue Growth Rate 2016-2021 (US$ Million) Figure 41. North America Non-Invasive Drug Delivery Sales Market Share by Country in 2020 Figure 42. North America Non-Invasive Drug Delivery Revenue Market Share by Country in 2020 Figure 43. U.S. Non-Invasive Drug Delivery Sales Growth Rate (2016-2021) (K Units) Figure 44. U.S. Non-Invasive Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Canada Non-Invasive Drug Delivery Sales Growth Rate (2016-2021) (K Units) Figure 46. Canada Non-Invasive Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million) Figure 47. Europe Non-Invasive Drug Delivery Sales Growth Rate 2016-2021 (K Units) Figure 48. Europe Non-Invasive Drug Delivery Revenue Growth Rate 2016-2021 (US$ Million) Figure 49. Europe Non-Invasive Drug Delivery Sales Market Share by Country in 2020 Figure 50. Europe Non-Invasive Drug Delivery Revenue Market Share by Country in 2020 Figure 51. Germany Non-Invasive Drug Delivery Sales Growth Rate (2016-2021) (K Units) Figure 52. Germany Non-Invasive Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million) Figure 53. France Non-Invasive Drug Delivery Sales Growth Rate (2016-2021) (K Units) Figure 54. France Non-Invasive Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million) Figure 55. U.K. Non-Invasive Drug Delivery Sales Growth Rate (2016-2021) (K Units) Figure 56. U.K. Non-Invasive Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million) Figure 57. Italy Non-Invasive Drug Delivery Sales Growth Rate (2016-2021) (K Units) Figure 58. Italy Non-Invasive Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million) Figure 59. Russia Non-Invasive Drug Delivery Sales Growth Rate (2016-2021) (K Units) Figure 60. Russia Non-Invasive Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million) Figure 61. Asia Pacific Non-Invasive Drug Delivery Sales Growth Rate 2016-2021 (K Units) Figure 62. Asia Pacific Non-Invasive Drug Delivery Revenue Growth Rate 2016-2021 (US$ Million) Figure 63. Asia Pacific Non-Invasive Drug Delivery Sales Market Share by Region in 2020 Figure 64. Asia Pacific Non-Invasive Drug Delivery Revenue Market Share by Region in 2020 Figure 65. China Non-Invasive Drug Delivery Sales Growth Rate (2016-2021) (K Units) Figure 66. China Non-Invasive Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million) Figure 67. Japan Non-Invasive Drug Delivery Sales Growth Rate (2016-2021) (K Units) Figure 68. Japan Non-Invasive Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million) Figure 69. South Korea Non-Invasive Drug Delivery Sales Growth Rate (2016-2021) (K Units) Figure 70. South Korea Non-Invasive Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million) Figure 71. India Non-Invasive Drug Delivery Sales Growth Rate (2016-2021) (K Units) Figure 72. India Non-Invasive Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million) Figure 73. Australia Non-Invasive Drug Delivery Sales Growth Rate (2016-2021) (K Units) Figure 74. Australia Non-Invasive Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million) Figure 75. Taiwan Non-Invasive Drug Delivery Sales Growth Rate (2016-2021) (K Units) Figure 76. Taiwan Non-Invasive Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million) Figure 77. Indonesia Non-Invasive Drug Delivery Sales Growth Rate (2016-2021) (K Units) Figure 78. Indonesia Non-Invasive Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million) Figure 79. Thailand Non-Invasive Drug Delivery Sales Growth Rate (2016-2021) (K Units) Figure 80. Thailand Non-Invasive Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million) Figure 81. Malaysia Non-Invasive Drug Delivery Sales Growth Rate (2016-2021) (K Units) Figure 82. Malaysia Non-Invasive Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million) Figure 83. Philippines Non-Invasive Drug Delivery Sales Growth Rate (2016-2021) (K Units) Figure 84. Philippines Non-Invasive Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million) Figure 85. Vietnam Non-Invasive Drug Delivery Sales Growth Rate (2016-2021) (K Units) Figure 86. Vietnam Non-Invasive Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million) Figure 87. Latin America Non-Invasive Drug Delivery Sales Growth Rate 2016-2021 (K Units) Figure 88. Latin America Non-Invasive Drug Delivery Revenue Growth Rate 2016-2021 (US$ Million) Figure 89. Latin America Non-Invasive Drug Delivery Sales Market Share by Country in 2020 Figure 90. Latin America Non-Invasive Drug Delivery Revenue Market Share by Country in 2020 Figure 91. Mexico Non-Invasive Drug Delivery Sales Growth Rate (2016-2021) (K Units) Figure 92. Mexico Non-Invasive Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million) Figure 93. Brazil Non-Invasive Drug Delivery Sales Growth Rate (2016-2021) (K Units) Figure 94. Brazil Non-Invasive Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million) Figure 95. Argentina Non-Invasive Drug Delivery Sales Growth Rate (2016-2021) (K Units) Figure 96. Argentina Non-Invasive Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million) Figure 97. Middle East and Africa Non-Invasive Drug Delivery Sales Growth Rate 2016-2021 (K Units) Figure 98. Middle East and Africa Non-Invasive Drug Delivery Revenue Growth Rate 2016-2021 (US$ Million) Figure 99. Middle East and Africa Non-Invasive Drug Delivery Sales Market Share by Country in 2020 Figure 100. Middle East and Africa Non-Invasive Drug Delivery Revenue Market Share by Country in 2020 Figure 101. Turkey Non-Invasive Drug Delivery Sales Growth Rate (2016-2021) (K Units) Figure 102. Turkey Non-Invasive Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million) Figure 103. Saudi Arabia Non-Invasive Drug Delivery Sales Growth Rate (2016-2021) (K Units) Figure 104. Saudi Arabia Non-Invasive Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million) Figure 105. UAE Non-Invasive Drug Delivery Sales Growth Rate (2016-2021) (K Units) Figure 106. UAE Non-Invasive Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million) Figure 107. Non-Invasive Drug Delivery Value Chain Figure 108. Channels of Distribution Figure 109. Distributors Profiles Figure 110. Bottom-up and Top-down Approaches for This Report Figure 111. Data Triangulation Figure 112. Key Executives Interviewed

Adherium Limited Capsule Technologies, Inc. Crossject S.A. Diabeloop SA HNS International, Inc. Inovio Pharmaceuticals, Inc. Medtronic Plc. Novartis AG PenJet Corporation PharmaJet Portal Instruments ResMed Sensiron AG Tandem Diabetes Care, Inc. Teva Pharmaceuticals Industries Ltd.